Trinity Health Mid-Atlantic, which signed a preliminary agreement to buy Tower Health’s Chestnut Hill Hospital in September, will not complete the deal, leaving the facility to continue operating under a cloud of uncertainty, The Philadelphia Inquirer reports.
“Trinity Health Mid-Atlantic determined that it could not identify enough synergies that would result in substantial benefits for patients and the community,” Tower CEO P. Sue Perrotty wrote in a memo to employees Thursday.
Tower said it does not plan to close Chestnut Hill, which has been packed with COVID-19 patients during the current surge, and will continue exploring a sale. The hospital and others in the Tower system have been up for sale since the fall of 2020. Read more.
